DE60125411D1 - Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung - Google Patents

Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung

Info

Publication number: DE60125411D1
Authority: DE; Germany
Prior art keywords: pharmaceutical; parenteral administration; dronedarone; composition; dronedarone composition
Prior art date: 2000-12-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60125411T

Other languages

English (en)

Other versions

DE60125411T2 (de

Inventor

Frederique Bourriague-Seve

Thierry Breul

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Sanofi Aventis France

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-11

Filing date

2001-12-10

Publication date

2007-02-01

2001-12-10 Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France

2007-02-01 Application granted granted Critical

2007-02-01 Publication of DE60125411D1 publication Critical patent/DE60125411D1/de

2007-10-11 Publication of DE60125411T2 publication Critical patent/DE60125411T2/de

2021-12-11 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

DE60125411T 2000-12-11 2001-12-10 Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung Expired - Lifetime DE60125411T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0016071		2000-12-11
FR0016071A FR2817750B1 (fr)	2000-12-11	2000-12-11	Composition pharmaceutique de dronedarone pour administration parenterale
PCT/FR2001/003903 WO2002047660A1 (fr)	2000-12-11	2001-12-10	Composition pharmaceutique de dronedarone pour administration parenterale

Publications (2)

Publication Number	Publication Date
DE60125411D1 true DE60125411D1 (de)	2007-02-01
DE60125411T2 DE60125411T2 (de)	2007-10-11

Family

ID=8857483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60125411T Expired - Lifetime DE60125411T2 (de)	2000-12-11	2001-12-10	Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung

Country Status (30)

Country	Link
US (1)	US6939865B2 (de)
EP (1)	EP1343473B1 (de)
JP (1)	JP4399161B2 (de)
KR (1)	KR100849758B1 (de)
CN (1)	CN1235566C (de)
AR (1)	AR031649A1 (de)
AT (1)	ATE348599T1 (de)
AU (2)	AU2002217229B2 (de)
BG (1)	BG66187B1 (de)
BR (1)	BR0116060B1 (de)
CA (1)	CA2427375C (de)
CZ (1)	CZ297788B6 (de)
DE (1)	DE60125411T2 (de)
EA (1)	EA005314B1 (de)
FR (1)	FR2817750B1 (de)
HU (1)	HU229372B1 (de)
IL (2)	IL155428A0 (de)
IS (1)	IS2349B (de)
MA (1)	MA26969A1 (de)
ME (2)	ME00083B (de)
MX (1)	MXPA03005221A (de)
NO (1)	NO332294B1 (de)
NZ (1)	NZ525661A (de)
OA (1)	OA12416A (de)
PL (1)	PL199846B1 (de)
RS (1)	RS50348B (de)
SK (1)	SK287115B6 (de)
TW (1)	TWI246926B (de)
WO (1)	WO2002047660A1 (de)
ZA (1)	ZA200303406B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1984028A2 (de) *	2006-02-14	2008-10-29	Wyeth a Corporation of the State of Delaware	Wässrige pharmazeutische formulierungen er-selektiver liganden
GB0719180D0 (en) *	2007-10-02	2007-11-14	Cambrex Karlskoga Ab	New process
TWI519298B (zh) *	2008-04-17	2016-02-01	賽諾菲安萬特公司	決奈達隆（ｄｒｏｎｅｄａｒｏｎｅ）於製備用於預防心血管疾病住院或死亡之藥劑之用途
FR2930149B1 (fr) *	2008-04-17	2011-02-18	Sanofi Aventis	Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2116239A1 (de) *	2008-04-29	2009-11-11	Sanofi-Aventis	Verfahren zur Verwaltung von Risiken in Zusammenhang mit der Zunahme von Serumkreatinin bei der Dronedaron-Behandlung
FR2959132A1 (fr) *	2010-04-22	2011-10-28	Sanofi Aventis	Procedes pour l'evaluation et la reduction des risques
TWI508726B (zh)	2009-12-21	2015-11-21	Gilead Sciences Inc	治療心房纖維性顫動之方法
US20120005128A1 (en) *	2010-06-29	2012-01-05	Sanofi	Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation
US8602215B2 (en)	2010-06-30	2013-12-10	Sanofi	Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
CN102342907A (zh)	2010-07-30	2012-02-08	江苏恒瑞医药股份有限公司	决奈达隆固体分散体及其制备方法
KR20120094557A (ko) *	2011-02-01	2012-08-27	동아제약주식회사	피에이치 비의존적 용출양상을 갖는 부정맥치료제 제제
CN102908307A (zh) *	2011-08-03	2013-02-06	天津市嵩锐医药科技有限公司	供注射用盐酸决奈达隆药物组合物及其制备方法
KR20150030761A (ko) *	2012-07-12	2015-03-20	사노피	화합물 1-(6-｛[6-(4-플루오로페닐)[1,2,4]트리아졸로[4,3-b]피리다진-3-일]술파닐｝-1,3-벤조티아졸-2-일)-3-(2-모르폴린-4-일에틸)우레아를 포함하는 항종양 조성물
TWI901795B (zh) *	2020-10-20	2025-10-21	大陸商上海雲晟研新生物科技有限公司	鹽酸決奈達隆藥物組合物、其製備方法及應用
CN115702878B (zh) *	2021-08-16	2024-05-10	上海云晟研新生物科技有限公司	盐酸决奈达隆注射组合物、其制备方法及应用
IL319907A (en) *	2022-12-07	2025-05-01	Remegen Co Ltd	TACI-FC fusion protein in a medical preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4727064A (en) *	1984-04-25	1988-02-23	The United States Of America As Represented By The Department Of Health And Human Services	Pharmaceutical preparations containing cyclodextrin derivatives
FR2746013B1 (fr) *	1996-03-18	1998-05-29	Sanofi Sa	Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
JP2004327321A (ja) *	2003-04-25	2004-11-18	Jst Mfg Co Ltd	コネクタ

2000
- 2000-12-11 FR FR0016071A patent/FR2817750B1/fr not_active Expired - Fee Related
2001
- 2001-12-10 EP EP01270322A patent/EP1343473B1/de not_active Expired - Lifetime
- 2001-12-10 MX MXPA03005221A patent/MXPA03005221A/es active IP Right Grant
- 2001-12-10 CZ CZ20031612A patent/CZ297788B6/cs not_active IP Right Cessation
- 2001-12-10 AR ARP010105716A patent/AR031649A1/es not_active Application Discontinuation
- 2001-12-10 ZA ZA200303406A patent/ZA200303406B/en unknown
- 2001-12-10 DE DE60125411T patent/DE60125411T2/de not_active Expired - Lifetime
- 2001-12-10 AT AT01270322T patent/ATE348599T1/de not_active IP Right Cessation
- 2001-12-10 NZ NZ525661A patent/NZ525661A/en not_active IP Right Cessation
- 2001-12-10 OA OA1200300152A patent/OA12416A/fr unknown
- 2001-12-10 JP JP2002549234A patent/JP4399161B2/ja not_active Expired - Fee Related
- 2001-12-10 ME MEP-2008-204A patent/ME00083B/me unknown
- 2001-12-10 SK SK726-2003A patent/SK287115B6/sk not_active IP Right Cessation
- 2001-12-10 TW TW090130522A patent/TWI246926B/zh not_active IP Right Cessation
- 2001-12-10 CA CA2427375A patent/CA2427375C/fr not_active Expired - Fee Related
- 2001-12-10 US US10/450,320 patent/US6939865B2/en not_active Expired - Lifetime
- 2001-12-10 HU HU0500842A patent/HU229372B1/hu not_active IP Right Cessation
- 2001-12-10 BR BRPI0116060-5B1A patent/BR0116060B1/pt not_active IP Right Cessation
- 2001-12-10 PL PL362788A patent/PL199846B1/pl unknown
- 2001-12-10 CN CNB018203884A patent/CN1235566C/zh not_active Expired - Fee Related
- 2001-12-10 WO PCT/FR2001/003903 patent/WO2002047660A1/fr not_active Ceased
- 2001-12-10 IL IL15542801A patent/IL155428A0/xx active IP Right Grant
- 2001-12-10 AU AU2002217229A patent/AU2002217229B2/en not_active Ceased
- 2001-12-10 AU AU1722902A patent/AU1722902A/xx active Pending
- 2001-12-10 EA EA200300406A patent/EA005314B1/ru not_active IP Right Cessation
- 2001-12-10 KR KR1020037007744A patent/KR100849758B1/ko not_active Expired - Fee Related
- 2001-12-10 ME MEP-204/08A patent/MEP20408A/xx unknown
- 2001-12-10 RS YUP-465/03A patent/RS50348B/sr unknown
2003
- 2003-04-14 IL IL155428A patent/IL155428A/en not_active IP Right Cessation
- 2003-04-18 BG BG107748A patent/BG66187B1/bg unknown
- 2003-04-29 NO NO20031958A patent/NO332294B1/no not_active IP Right Cessation
- 2003-04-30 IS IS6801A patent/IS2349B/is unknown
- 2003-06-03 MA MA27190A patent/MA26969A1/fr unknown

Also Published As

Publication number	Publication date
FR2817750A1 (fr)	2002-06-14
JP2004528277A (ja)	2004-09-16
IL155428A0 (en)	2003-11-23
CZ20031612A3 (cs)	2003-09-17
BG66187B1 (bg)	2011-12-30
EA005314B1 (ru)	2004-12-30
EA200300406A1 (ru)	2003-10-30
IL155428A (en)	2007-10-31
JP4399161B2 (ja)	2010-01-13
EP1343473B1 (de)	2006-12-20
ATE348599T1 (de)	2007-01-15
NO20031958D0 (no)	2003-04-29
CA2427375A1 (fr)	2002-06-20
CN1479610A (zh)	2004-03-03
PL362788A1 (en)	2004-11-02
ME00083B (me)	2010-10-10
RS50348B (sr)	2009-11-10
US6939865B2 (en)	2005-09-06
PL199846B1 (pl)	2008-11-28
BG107748A (bg)	2004-03-31
WO2002047660A1 (fr)	2002-06-20
OA12416A (fr)	2006-04-18
CN1235566C (zh)	2006-01-11
HK1055906A1 (en)	2004-01-30
YU46503A (sh)	2006-08-17
NZ525661A (en)	2004-11-26
TWI246926B (en)	2006-01-11
MXPA03005221A (es)	2004-03-26
IS6801A (is)	2003-04-30
MA26969A1 (fr)	2004-12-20
NO332294B1 (no)	2012-08-20
IS2349B (is)	2008-04-15
DE60125411T2 (de)	2007-10-11
EP1343473A1 (de)	2003-09-17
NO20031958L (no)	2003-06-11
AU2002217229B2 (en)	2006-05-18
SK7262003A3 (en)	2004-02-03
ZA200303406B (en)	2004-05-03
CA2427375C (fr)	2011-02-01
HUP0500842A2 (hu)	2005-12-28
BR0116060B1 (pt)	2013-12-31
US20040044070A1 (en)	2004-03-04
AR031649A1 (es)	2003-09-24
HU229372B1 (en)	2013-11-28
KR100849758B1 (ko)	2008-07-31
BR0116060A (pt)	2004-03-02
MEP20408A (en)	2010-06-10
SK287115B6 (sk)	2009-12-07
AU1722902A (en)	2002-06-24
FR2817750B1 (fr)	2003-02-21
CZ297788B6 (cs)	2007-03-28
KR20030060985A (ko)	2003-07-16

Publication	Publication Date	Title
DE60142197D1 (de)	2010-07-01	Pharmazeutische Zusammensetzung
NO20030627L (no)	2003-04-08	Hydrogel-drevet medikament doseringsform
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
FI991485L (fi)	2000-12-31	Uusi farmaseuttinen koostumus
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
NO20015175D0 (no)	2001-10-23	Farmasöytisk sammensetning
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
NO20022970L (no)	2002-06-20	Hydrogel-drevet medikamentdoseringsform
DE60118008D1 (de)	2006-05-11	Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE60125411D1 (de)	2007-02-01	Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
ATE366128T1 (de)	2007-07-15	Pharmazeutische zusammensetzung
AU2002217229A1 (en)	2002-08-29	Pharmaceutical dronedarone composition for parenteral administration
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
EA200201062A1 (ru)	2003-02-27	Фармацевтическая композиция на основе нестероидного противовоспалительного средства
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
EE200200689A (et)	2004-06-15	Ravimkoostised
SE0004677D0 (sv)	2000-12-18	Intraaxonal läkemedelsadministration

Legal Events

Date	Code	Title	Description
2008-01-10	8364	No opposition during term of opposition